Moses Victor Javier Aguilar, Chief Research, Development and Innovation Officer at Procter & Gamble Co, filed a Form 4 on November 3, 2026, disclosing the exercise of stock options and the same-day sale of 18,812 shares of common stock on October 30, 2026.

Key Highlights

  • Option exercise: Aguilar exercised a stock option (transaction code M) to acquire 18,812 shares of common stock at an exercise price of $78.52 per share on October 30, 2026.
  • Shares sold: All 18,812 acquired shares were sold the same day (transaction code S) at a weighted average price of $164.4342, with the price range noted as $164.39 to $164.515.
  • Direct ownership after transactions: Following the reported transactions, Aguilar directly held 55,243.0935 shares of common stock.
  • Indirect holdings: An additional 7,546.1382 shares are held indirectly through a Retirement Plan Trustee, and 428.6033 shares through an International Stock Ownership Plan (Mexico) Trustee.
  • Option now closed: The stock option, which was exercisable from February 26, 2021, and set to expire February 28, 2028, shows zero derivative securities remaining following the exercise.
  • Filing role: The form was signed by Jennifer DollardSmith as attorney-in-fact for Mr. Victor Aguilar Moses on November 3, 2026.

Aguilar Moses Option Exercise and Share Sale at Procter & Gamble

According to the Form 4 filing submitted to the SEC, Moses Victor Javier Aguilar, serving as Chief Research, Development and Innovation Officer of Procter & Gamble Co (NYSE:PG), exercised a stock option on October 30, 2026, acquiring 18,812 shares of common stock at the option's exercise price of $78.52 per share. The option had been exercisable since February 26, 2021, and carried an expiration date of February 28, 2028. Following the exercise, zero options of this grant remain, as reported in Table II of the filing.

On the same date, the filing reports that Aguilar disposed of all 18,812 shares through an open-market sale at a weighted average price of $164.4342. The filing notes that the actual price range for these sales was $164.39 to $164.515, and states that "full information regarding the number of shares sold at each separate price available upon request." After both transactions, Aguilar's direct beneficial ownership stood at 55,243.0935 shares of common stock, according to the filing.

In addition to his direct holdings, the filing discloses two indirect ownership positions: 7,546.1382 shares held through a Retirement Plan Trustee, which the filing notes reflects an adjustment to a profit-sharing trust (PST) through September 30, 2026, and 428.6033 shares held through an International Stock Ownership Plan (Mexico) Trustee. No other transactions were reported in the filing.

What Was Disclosed

The filing disclosed Aguilar's exercise of 18,812 stock options at $78.52 and same-day sale of the resulting shares at a weighted average of $164.4342 on October 30, 2026, along with his updated direct and indirect beneficial ownership positions in Procter & Gamble common stock.